Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jeffrey R Olsen

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-RADONC General Operations
Phone719/365-5739

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kim H, Olsen JR, Green OL, Chin RI, Hawkins WG, Fields RC, Hammill C, Doyle MB, Chapman W, Suresh R, Tan B, Pedersen K, Jansen B, DeWees TA, Lu E, Henke LE, Badiyan S, Parikh PJ, Roach MC, Wang-Gillam A, Lim KH. MR-guided radiation therapy with concurrent gemcitabine / nab-paclitaxel chemotherapy in inoperable pancreatic cancer: a TITE-CRM phase I trial. Int J Radiat Oncol Biol Phys. 2022 Jul 22. PMID: 35878713.
      View in: PubMed
    2. Buckstein MH, Anker CJ, Chuong MD, Hawkins MA, Kharofa J, Olsen JR. CROSSing into New Therapies for Esophageal Cancer. Int J Radiat Oncol Biol Phys. 2022 05 01; 113(1):5-10. PMID: 35427559.
      View in: PubMed
    3. Chapman BC, Lai S, Friedrich T, Lieu CH, Moskalenko M, Olsen J, Herter W, Birnbaum EH, McCarter MD, Vogel JD. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy. Dis Colon Rectum. 2022 Jan 04. PMID: 34984995.
      View in: PubMed
    4. Anker CJ, Buckstein MH, Chuong MD, Hawkins MA, Kharofa J, Raldow AC, Tait D, Olsen JR. The Evolving Personalized Landscape of Colorectal Cancer Therapies. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1255-1262. PMID: 34273318.
      View in: PubMed
    5. Kim H, Pedersen K, Olsen JR, Mutch MG, Chin RI, Glasgow SC, Wise PE, Silviera ML, Tan BR, Wang-Gillam A, Lim KH, Suresh R, Amin M, Huang Y, Henke LE, Park H, Ciorba MA, Badiyan S, Parikh PJ, Roach MC, Hunt SR. Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial. Clin Colorectal Cancer. 2021 09; 20(3):e185-e193. PMID: 34001462.
      View in: PubMed
    6. Robin TP, Olsen JR. SABR for metastasis-directed therapy - what we've learned and what's to come. Nat Rev Clin Oncol. 2020 10; 17(10):593-594. PMID: 32699308.
      View in: PubMed
    7. Olsen JR, Apisarnthanarax S, Murphy JD, Tait D, Huguet F, Hallemeier CL, Jabbour SK. Gastrointestinal Cancers: Fine-Tuning the Management of Rectal, Esophageal, and Pancreas Cancers. Int J Radiat Oncol Biol Phys. 2019 09 01; 105(1):1-10. PMID: 31422802.
      View in: PubMed
    8. Hallemeier CL, Olsen JR, Murphy JD, Tait D, Apisarnthanarax S, Huguet F, Jabbour SK. Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):1-9. PMID: 30967220.
      View in: PubMed
    9. Rudra S, Jiang N, Rosenberg SA, Olsen JR, Roach MC, Wan L, Portelance L, Mellon EA, Bruynzeel A, Lagerwaard F, Bassetti MF, Parikh PJ, Lee PP. Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Med. 2019 05; 8(5):2123-2132. PMID: 30932367.
      View in: PubMed
    10. Olsen JR, Schefter TE. SBRT as a Favored Ablative Therapy for Stage I HCC. Int J Radiat Oncol Biol Phys. 2018 12 01; 102(5):1406. PMID: 31014784.
      View in: PubMed
    11. Henke LE, Olsen JR, Contreras JA, Curcuru A, DeWees TA, Green OL, Michalski J, Mutic S, Roach MC, Bradley JD, Parikh PJ, Kashani R, Robinson CG. Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial. Adv Radiat Oncol. 2019 Jan-Mar; 4(1):201-209. PMID: 30706029.
      View in: PubMed
    12. Olsen JR, Murphy JD, Huguet F, Hallemeier CL, Apisarnthanarax S, Jabbour SK. Gastrointestinal Cancers-Carving Out the Optimal Local Therapies in the Gastrointestinal Tract. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):233-242. PMID: 30191854.
      View in: PubMed
    13. Gui B, Weiner AA, Nosher J, Lu SE, Foltz GM, Hasan O, Kim SK, Gendel V, Mani NB, Carpizo DR, Saad NE, Kennedy TJ, Zuckerman DA, Olsen JR, Parikh PJ, Jabbour SK. Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. Am J Clin Oncol. 2018 09; 41(9):861-866. PMID: 28418940.
      View in: PubMed
    14. Rosenberg SA, Henke LE, Shaverdian N, Mittauer K, Wojcieszynski AP, Hullett CR, Kamrava M, Lamb J, Cao M, Green OL, Kashani R, Paliwal B, Bayouth J, Harari PM, Olsen JR, Lee P, Parikh PJ, Bassetti M. A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy. Adv Radiat Oncol. 2019 Jan-Mar; 4(1):142-149. PMID: 30706022.
      View in: PubMed
    15. Jabbour SK, Apisarnthanarax S, Hallemeier CL, Huguet F, Murphy JD, Olsen JR. GI Cancers-Modulating the Modern Management of Gastrointestinal Malignancies: A Look at Liver Metastases, Rectal Cancer, Esophagogastric Cancer, and Anal Cancer. Int J Radiat Oncol Biol Phys. 2018 07 15; 101(4):749-758. PMID: 29976479.
      View in: PubMed
    16. Green OL, Rankine LJ, Cai B, Curcuru A, Kashani R, Rodriguez V, Li HH, Parikh PJ, Robinson CG, Olsen JR, Mutic S, Goddu SM, Santanam L. First clinical implementation of real-time, real anatomy tracking and radiation beam control. Med Phys. 2018 May 28. PMID: 29807390.
      View in: PubMed
    17. Weiner AA, Gui B, Newman NB, Nosher JL, Yousseff F, Lu SE, Foltz GM, Carpizo D, Lowenthal J, Zuckerman DA, Benson B, Olsen JR, Jabbour SK, Parikh PJ. Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases. J Vasc Interv Radiol. 2018 08; 29(8):1094-1100. PMID: 29754852.
      View in: PubMed
    18. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 29114617.
      View in: PubMed
    19. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 29165271.
      View in: PubMed
    20. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 28740875.
      View in: PubMed
    21. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 28871992.
      View in: PubMed
    22. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 18037590.
      View in: PubMed
    23. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 27742541.
      View in: PubMed
    24. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 29933877.
      View in: PubMed
    25. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 29945521.
      View in: PubMed
    26. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 30827451.
      View in: PubMed
    27. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 32092337.
      View in: PubMed
    28. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 32092335.
      View in: PubMed
    29. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 20888130.
      View in: PubMed
    30. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 33422270.
      View in: PubMed
    31. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 24367866.
      View in: PubMed
    32. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 23287852.
      View in: PubMed
    33. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 12086478.
      View in: PubMed
    34. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 33470210.
      View in: PubMed
    35. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 33864283.
      View in: PubMed
    36. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 23023940.
      View in: PubMed
    37. Cardenas ML, Spencer CR, Markovina S, DeWees TA, Mazur TR, Weiner AA, Parikh PJ, Olsen JR. Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):281-287. PMID: 29114593.
      View in: PubMed
    38. Olsen JR, Moughan J, Myerson R, Abitbol A, Doncals DE, Johnson D, Schefter TE, Chen Y, Fisher B, Michalski J, Narayan S, Chang A, Crane CH, Kachnic L. Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):400-408. PMID: 28463160.
      View in: PubMed
    39. Cai B, Altman MB, Garcia-Ramirez J, LaBrash J, Goddu SM, Mutic S, Parikh PJ, Olsen JR, Saad N, Zoberi JE. Process improvement for the safe delivery of multidisciplinary-executed treatments-A case in Y-90 microspheres therapy. Brachytherapy. 2017 Jan - Feb; 16(1):236-244. PMID: 27618420.
      View in: PubMed
    40. Roy A, Mahasittiwat P, Weiner AA, Hunt SR, Mutch MG, Birnbaum EH, Kodner IJ, Read TE, Fleshman JW, Olsen JR, Myerson RJ, Parikh PJ. Preoperative short-course radiation therapy for rectal cancer provides excellent disease control and toxicity: Results from a single US institution. Pract Radiat Oncol. 2017 Jan - Feb; 7(1):e51-e58. PMID: 27720702.
      View in: PubMed
    41. Khwaja SS, Roy A, Markovina S, Dewees TA, Hunt S, Tan B, Myerson RJ, Olsen JR, Parikh PJ. Quality of Life Outcomes From a Phase 2 Trial of Short-Course Radiation Therapy Followed by FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer. Int J Radiat Oncol Biol Phys. 2016 08 01; 95(5):1429-1438. PMID: 27209506.
      View in: PubMed
    42. Badiyan SN, Olsen JR, Lee AY, Yano M, Menias CO, Khwaja S, Wang-Gillam A, Strasberg SM, Hawkins WG, Linehan DC, Myerson RJ, Parikh PJ. Induction Chemotherapy Followed by Concurrent Full-dose Gemcitabine and Intensity-modulated Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma. Am J Clin Oncol. 2016 Feb; 39(1):1-7. PMID: 26132367.
      View in: PubMed
    43. Elhammali A, Patel M, Weinberg B, Verma V, Liu J, Olsen JR, Gay HA. Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas. Radiat Oncol. 2015 Sep 04; 10:186. PMID: 26337917.
      View in: PubMed
    44. Noel CE, Parikh PJ, Spencer CR, Green OL, Hu Y, Mutic S, Olsen JR. Comparison of onboard low-field magnetic resonance imaging versus onboard computed tomography for anatomy visualization in radiotherapy. Acta Oncol. 2015; 54(9):1474-82. PMID: 26206517.
      View in: PubMed
    45. Du L, DeFoe M, Ruzinova MB, Olsen JR, Wang-Gillam A. Perioperative Therapy for Surgically Resectable Pancreatic Adenocarcinoma. Hematol Oncol Clin North Am. 2015 Aug; 29(4):717-26. PMID: 26226906.
      View in: PubMed
    46. Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RLM, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1053-1059. PMID: 26194680.
      View in: PubMed
    47. Hu Y, Zhao W, Du D, Wooten HO, Olsen JR, Gay HA, Michalski JM, Mutic S. Magnetic resonance imaging-based treatment planning for prostate cancer: Use of population average tissue densities within the irradiated volume to improve plan accuracy. Pract Radiat Oncol. 2015 Jul-Aug; 5(4):248-56. PMID: 25649539.
      View in: PubMed
    48. Badiyan SN, Bierhals AJ, Olsen JR, Creach KM, Garsa AA, Dewees T, Bradley JD, Robinson CG. Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis. Radiat Oncol. 2013 Jan 03; 8:4. PMID: 23286648.
      View in: PubMed
    49. Olsen JR, Parikh PJ, Watts M, Noel CE, Baker KW, Santanam L, Michalski JM. Comparison of dose decrement from intrafraction motion for prone and supine prostate radiotherapy. Radiother Oncol. 2012 Aug; 104(2):199-204. PMID: 22809590.
      View in: PubMed
    50. Creach KM, El Naqa I, Bradley JD, Olsen JR, Parikh PJ, Drzymala RE, Bloch C, Robinson CG. Dosimetric predictors of chest wall pain after lung stereotactic body radiotherapy. Radiother Oncol. 2012 Jul; 104(1):23-7. PMID: 22385795.
      View in: PubMed
    51. Olsen JR, Robinson CG, El Naqa I, Creach KM, Drzymala RE, Bloch C, Parikh PJ, Bradley JD. Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 15; 81(4):e299-303. PMID: 21477948.
      View in: PubMed
    52. Olsen JR, Noel CE, Baker K, Santanam L, Michalski JM, Parikh PJ. Practical method of adaptive radiotherapy for prostate cancer using real-time electromagnetic tracking. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):1903-11. PMID: 21470786.
      View in: PubMed
    Olsen's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)